Drug Type miRNA |
Synonyms QTsome/AM-21 |
Target |
Mechanism miR-21 agonists(microRNA 21 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | US | 19 Jan 2016 | |
Non-Small Cell Lung Cancer | Discovery | US | - | |
Ovarian adenocarcinoma | Discovery | US | - |